Neutropenia in adults – significant diagnostic issue

1. Gibson Ch, Berliner N. How we evaluate and treat neutropenia in adults. Blood. 2014; 124 (8):1251-1258.10.1182/blood-2014-02-48261224869938Search in Google Scholar

2. Newburger P, Dale D. Evaluation and management of patients with isolated neutropenia. Semin Hematol. 2013; 50 (3): 198-206.10.1053/j.seminhematol.2013.06.010374838523953336Open DOISearch in Google Scholar

3. Gołąb J., Jakóbisiak M. Rozpoznanie drobnoustrojów przez nieswoiste mechanizmy odporności. [w:] Gołąb J, Jakóbsiak M, Lasek W i wsp., red. Immunologia. Nowe wydanie. Warszawa: PWN; 2014, s.234-235.Search in Google Scholar

4. Kabata J, Hellman A. Choroby układu krwiotwórczego. Badania laboratoryjne i morfologiczne, [w:] Gajewski P, Interna Szczeklik. Podręcznik chorób wewnętrznych 2014. Medycyna Praktyczna. Kraków; 2014, s. 1578-1579.Search in Google Scholar

5. Boxer L. How to approach neutropenia. ASH Education Book. 2012; (1): 174-182.10.1182/asheducation.V2012.1.174.3798251Search in Google Scholar

6. Palmblad J, Nilson Ch, Hoglund P, et al. How we diagnose and treat neutropenia in adults. Expert Rev. Hematol. 2016; 9 (5):479-487.Search in Google Scholar

7. http://www.genecards.org/cgi-bin/carddisp.pl?gene=ACKR1, dostęp: 10.08.2017.Search in Google Scholar

8. Vandenberghe P, Beel K. Severe congenital neutropenia, a genetically heterogenous disease group with an increased risk of AML/MDS. Pediatr Rep. 2011; 3 (2):e9.10.4081/pr.2011.s2.e9320653722053285Search in Google Scholar

9. Rosenberg P, Alter B, Bolyard A. Severe Chronic Neutropenia International Registry. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood. 2006; 107 (12):4628-4635.10.1182/blood-2005-11-4370189580416497969Search in Google Scholar

10. Mansoor M, Khan M. A case of Cycylic Neutropenia in adults. J Pak Med Assoc. 2012; 62 (3):289-290.Search in Google Scholar

11. Huber M, Andersohn F, Bonder E, et al. Drug-induced agranulocytosis in the Berlin case-control surveillance study. Eur J Clin Pharmacol. 2014; 70 (3):339-345.10.1007/s00228-013-1618-124297345Open DOISearch in Google Scholar

12. Nakamura H, Miyauchi A, Miyawaki N, et al. Analysis of Antithyroid Drug-Induced Agranulocytosis Over 30 Years in Japan. Eur J Clin Pharmacol. 2014;70 (3):339-345.Search in Google Scholar

13. Zhong X, Lim EA, Hershman DL, et al. Identifying Severe Adverse Event Clusters Using the National Cancer Institute’s Common Terminology Criteria for Adverse Events. J Oncol Pract. 2016;12 (3): 245-246.10.1200/JOP.2015.006106570279326907453Search in Google Scholar

14. Potemski P. Neutropenia, [w:] Krzakowski M, Warzocha K. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych — 2013. Gdańsk: Via Medica; 2013, s. 537-547Search in Google Scholar

15. Kos-Zakrzewska K, Konopka L. Białaczka limfocytowa z dużych ziarnistych limfocytów T. Onkologia Polska. 2009; 12 (2):65-69.Search in Google Scholar

16. Robak T. Rzadsze przewlekłe białaczki limfoidalne. Acta Haematologica Polonica. 2011; 42 (3): 343–355.Search in Google Scholar

17. Lustberg M. Management of Neutropenia in Cancer Patients. Clin Adv Hematol Oncol. 2012; 12(10): 825–826.Search in Google Scholar

18. Hus M. Leczenie wspomagające w chorobach hematologicznych. [w:] Dmoszyńska A, Robak T, Hus I. Podstawy hematologii. Lublin: Czelej; 2015, s.414-422.Search in Google Scholar

19. Ebru R, Yalcinkaya-Erdemci Z, Burcak Cehreli S. Oral findings and clinical implications of patients with congenital neutropenia: a literature review. Turk J. Pediatr. 2013; 55 (3): 241-245.Search in Google Scholar

20. Rosenberg P, Zeidler C, Bolyard A, et al. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol. 2010; 150 (2):196–199.10.1111/j.1365-2141.2010.08216.x290669320456363Search in Google Scholar

21. Rosenberg P, Alter B, Bolyard A, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood. 2006; 107 (12): 4628–4635.10.1182/blood-2005-11-4370Search in Google Scholar

22. Coughlan M, Healy C. Nursing care, education and support for patients with neutropenia. Nursing standard. 2008; 46 (22): 35-41.10.7748/ns2008.07.22.46.35.c659818712243Search in Google Scholar